Guangzhou Yudong potassium chloride slow release film evaluation of the domestic oral mineral supplement competition pattern will change.

Table 1: Basic Information on Drugs Source: Company Announces Potassium Chloride Slow Release Tablets as electrolyte supplements for the treatment and prevention of hypothyroidism associated with or without metabolic alkali poisoning, the product is a class A variety in the national medical insurance catalogue and a variety in the national list of base drugs.
Figure 1: 2018 China's public medical institutions terminal chemical oral mineral supplement products TOP20 pattern Source: Minnet China public medical institutions terminal competition pattern announcement mentioned that potassium chloride slow release tablets were first developed by Upsher-Smith, April 17, 1986 in the United States.
There are currently 10 domestic enterprises in the market for production approval, and in 2018 sales of potassium chloride slow release tablets at the terminals of public hospitals, county-level public hospitals, urban community centers and township hospitals (china's public medical institutions) in China were 189 million yuan, a growth rate of 19.04 percent, ranking sixth in the top 20 pattern of oral mineral supplement products.
from the enterprise pattern, Guangzhou Yudong with 32% of the market share ranked second, and the first in the Haihong Nest Lake today between the pharmaceutical industry difference of less than 1%.
Guangzhou Yudong as the product's first over-rated enterprises, can take advantage of the opportunity to catch up, we wait for the results.
, Haihong Chaohu today's pharmaceutical industry of potassium chloride slow release tablet consistency evaluation supplement application is under review and approval, is expected to become the second over-evaluation.
source: Mi in-network database, company announcement original title: "Remarkable" oral mineral supplement TOP6 the first over-rated! The domestic competitive landscape will change.